U.S. doctors group sues FDA for limiting access to drug touted by Trump for COVID-19

The lawsuit represents the latest front in a highly politicized U.S. debate over access to hydroxychloroquine.The drug has been championed by President Donald Trump as a potential "game-changer" against the coronavirus, but its value has yet to be established.A clinical trial released on Wednesday found it to be ineffective in preventing infection.